Clinical Trial

FMD and Neoadjuvant Chemo-immunotherapy in TNBC

Name: FMD and Neoadjuvant Chemo-immunotherapy in TNBC — clinical trial record (NCT07378306)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FACT-TN

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to investigate the efficacy and safety of a fasting-mimicking diet (FMD) intervention combined with standard neoadjuvant chemoimmunotherapy in early-stage or locally advanced triple-negative breast cancer (TNBC).

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-22

Trial Details

NCT Number	NCT07378306
Lead Sponsor	Sun Yat-sen University
Conditions	Breast Cancer
Enrollment	80 participants
Start Date	2026-03-05
Primary Completion	2029-06-30 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-21